|
Thrombophilia
|
0.100 |
Biomarker
|
disease |
BEFREE |
PH is not associated with splenectomy status but correlated with NO depletion, TF-independent hypercoagulability and endothelial perturbation.
|
30584959 |
2019 |
|
Thrombophilia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
She also had shortened activated partial thromboplastin time indicating a hypercoagulable state and resulting in pulmonary embolism.
|
31362300 |
2019 |
|
Thrombophilia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We have previously shown that human monocyte-derived dendritic cells (moDCs) may participate in immune system-mediated hypercoagulable state through enhanced tissue factor (TF) expression and that the complement system may be involved in this process.
|
30893690 |
2019 |
|
Thrombophilia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Tumor-Specific Silencing of Tissue Factor Suppresses Metastasis and Prevents Cancer-Associated Hypercoagulability.
|
31180684 |
2019 |
|
Thrombophilia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Pancreatic cancer is characterised by high tumoural expression of tissue factor, activation of leukocytes with the release of neutrophil extracellular traps, the dissemination of tumour-derived microvesicles that promote hypercoagulability and increased platelet activation.
|
31327867 |
2019 |
|
Thrombophilia
|
0.100 |
Biomarker
|
disease |
BEFREE |
This study aimed to investigate whether circulating TF-positive MPs contributed to the hypercoagulable state in patients with IMN.
|
30429407 |
2019 |
|
Thrombophilia
|
0.100 |
Biomarker
|
disease |
BEFREE |
PAD4 and RAGE knockout mice, deficient in NET formation, were used to study the role of NETs in platelet aggregation, release of tissue factor and hypercoagulability.
|
29929491 |
2018 |
|
Thrombophilia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Due to a time-of-day effect present within TF, peaking at 0830, caution should be applied when prescribing short-duration high-intensity exercise bout within the morning in populations predisposed to hypercoagulability.
|
29320303 |
2018 |
|
Thrombophilia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
These results suggest a significant role of moDCs and the complement system through TF expression in a hypercoagulable state under inflammatory conditions and demonstrate the suppressive effects of C1 inhibitor on moDC-associated hypercoagulation.
|
29860607 |
2018 |
|
Thrombophilia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
HFP induces plasma hypercoagulability that is likely related to increased tissue factor and phosphatidylserine expression originating from cell-derived MP.
|
27941590 |
2017 |
|
Thrombophilia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Evidence suggests that cancer itself is associated with a state of hypercoagulability, driven in part by the release of procoagulant factors, such as tissue factor, from malignant tissue as well as by inflammation-driven activation of endothelial cells, platelets, and leukocytes.
|
27882374 |
2017 |
|
Thrombophilia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Emerging evidence suggests that indoxyl sulfate is implicated via novel mechanisms, including progenitor cell-related neovascularization and tissue factor-related hypercoagulability.
|
28067862 |
2017 |
|
Thrombophilia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Platelet activation has been associated with an epithelial to mesenchymal transition (EMT), while Tissue Factor (TF) protein expression by cancer cells has been shown to correlate with hypercoagulable state and metastasis.
|
25886038 |
2015 |
|
Thrombophilia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Cancer histology influences the risk of venous thromboembolism and tissue factor (TF) is the key molecule in cancer-induced hypercoagulability.
|
21917301 |
2012 |
|
Thrombophilia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Consequently, expression of tissue factor, urokinase receptor, and PAI-1 mRNA and PAI-1 protein secretion induced by busulfan were significantly reduced by the activin A/TGF-β1 inhibitor SB 431542 in ECV304 and primary endothelial cells.Conclusions This is the first report that directly relates busulfan exposure to antifibrinolytic activity by PAI-1 and hypercoagulation possibly mediated by members of the TGF-β1 family.
|
22286157 |
2012 |
|
Thrombophilia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Down-regulation of miR-19b and miR-20a observed in patients with SLE and APS could contribute to increased TF expression and thus provoke the hypercoagulable state characteristic of these patients.
|
21794077 |
2011 |
|
Thrombophilia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Collectively, our findings suggest that TF-specific PCA of plasma MPs contributes to intravascular coagulation activation in patients with early-stage prostate cancer and may represent a potential link between hypercoagulability, inflammation, and disease progression.
|
19492160 |
2009 |
|
Thrombophilia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Hypercoagulability and tissue factor gene upregulation in hematologic malignancies.
|
18645927 |
2008 |
|
Thrombophilia
|
0.100 |
Biomarker
|
disease |
BEFREE |
In conclusion we found a hypercoagulable state in patients with haematological malignancy that did not seem to be initiated by TF.
|
18521506 |
2008 |
|
Thrombophilia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
To investigate the influences of lowered tissue factor (TF) activity upon hypercoagulation of AT-/- embryos, we crossed AT+/- with low TF (mTF-/- hTF+) mice to yield homozygous AT-deficient mice with the extremely low TF activity, that is expressed from the inserted human TF mini gene.
|
16409467 |
2006 |
|
Thrombophilia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Whole blood thrombelastographic coagulation profiles using minimal tissue factor activation can display hypercoagulation in thrombosis-prone patients.
|
16777761 |
2006 |
|
Thrombophilia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Oncogenic events in cancer cells (e.g., expression of mutant K- ras, EGFR, PTEN or p53) lead to an increase in TF levels and activity, and thereby promote tumor aggressiveness, angiogenesis, and hypercoagulability.
|
16479463 |
2006 |
|
Thrombophilia
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
IFN and CRP further increase TF levels that may contribute to the hypercoagulable state in coronary disease.
|
16409458 |
2006 |
|
Thrombophilia
|
0.100 |
Biomarker
|
disease |
BEFREE |
We postulate that she had become tolerant to the systemic effects of endotoxin leaking from her inflamed colon but that the endotoxin stimulated her endothelium and/or monocytes to produce tissue factor that made her intensely hypercoagulable.
|
16131459 |
2005 |
|
Thrombophilia
|
0.100 |
Biomarker
|
disease |
BEFREE |
The higher availability of surface TF antigen on MNCs from HRs and TF-containing microparticles might make these individuals more susceptible to hypercoagulation.
|
15860742 |
2005 |